Literature DB >> 21113390

Emerging complexity of protein ubiquitination in the NF-κB pathway.

Hasem Habelhah1.   

Abstract

Members of the nuclear factor-κB (NF-κB) family of transcription factors play critical roles in regulating the expression of genes whose products are involved in inflammation, the immune response, cell proliferation, and the suppression of both death receptor- and stress-induced apoptosis. Abnormal NF-κB activation has been observed in various inflammatory diseases and many types of cancers. Gene knockout studies have clearly demonstrated that most of the physiologically relevant stimuli that activate NF-κB converge on inhibitor of κB kinase (IKK). Although the mechanism by which IKK activates NF-κB is well established, the upstream signaling mechanisms-those that underlie IKK activation by IKK kinases (IKK-Ks)-are not yet fully understood. The current belief is that members of the TNF receptor-associated factor (TRAF) family function as ubiquitin E3 ligases that catalyze non-canonical polyubiquitination of adaptor proteins, and that the ubiquitinated adaptor proteins in turn serve as platforms to recruit IKK and IKK-Ks, facilitating IKK activation through proximity-mediated phosphorylation. This review will focus on the most recent findings relating to the role of TRAFs-mediated protein ubiquitination in regulating IKK activation, and highlight the newly emerging complexity of protein ubiquitination in receptor-induced NF-κB activation.

Entities:  

Year:  2010        PMID: 21113390      PMCID: PMC2990976          DOI: 10.1177/1947601910382900

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  106 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

3.  The essential role of MEKK3 in TNF-induced NF-kappaB activation.

Authors:  J Yang; Y Lin; Z Guo; J Cheng; J Huang; L Deng; W Liao; Z Chen; Z Liu; B Su
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

4.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

Authors:  M van Hogerlinden; B L Rozell; L Ahrlund-Richter; R Toftgård
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

5.  Structural basis for recognition of diubiquitins by NEMO.

Authors:  Yu-Chih Lo; Su-Chang Lin; Carla C Rospigliosi; Dietrich B Conze; Chuan-Jin Wu; Jonathan D Ashwell; David Eliezer; Hao Wu
Journal:  Mol Cell       Date:  2009-01-29       Impact factor: 17.970

6.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Authors:  Sandra Gardam; Frederic Sierro; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2008-02-28       Impact factor: 31.745

8.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.

Authors:  Brian J Zarnegar; Yaya Wang; Douglas J Mahoney; Paul W Dempsey; Herman H Cheung; Jeannie He; Travis Shiba; Xiaolu Yang; Wen-Chen Yeh; Tak W Mak; Robert G Korneluk; Genhong Cheng
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.

Authors:  Matthew C Walsh; Gregory K Kim; Paul L Maurizio; Elizabeth E Molnar; Yongwon Choi
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more
  21 in total

1.  Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex.

Authors:  Yusuke Sato; Hiroaki Fujita; Azusa Yoshikawa; Masami Yamashita; Atsushi Yamagata; Stephen E Kaiser; Kazuhiro Iwai; Shuya Fukai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-02       Impact factor: 11.205

2.  TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice.

Authors:  Laiqun Zhang; Ken Blackwell; Lauren M Workman; Katherine N Gibson-Corley; Alicia K Olivier; Gail A Bishop; Hasem Habelhah
Journal:  J Cell Sci       Date:  2016-02-12       Impact factor: 5.285

3.  Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis.

Authors:  Alexey V Sorokin; Binoj C Nair; Yongkun Wei; Kathryn E Aziz; Valentina Evdokimova; Mien-Chie Hung; Junjie Chen
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

4.  Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Authors:  Claudia Lentucci; Anna C Belkina; Carly T Cederquist; Michelle Chan; Holly E Johnson; Sherry Prasad; Amanda Lopacinski; Barbara S Nikolajczyk; Stefano Monti; Jennifer Snyder-Cappione; Bogdan Tanasa; M Dafne Cardamone; Valentina Perissi
Journal:  J Biol Chem       Date:  2016-12-30       Impact factor: 5.157

5.  Protein-Binding Function of RNA-Dependent Protein Kinase Promotes Proliferation through TRAF2/RIP1/NF-κB/c-Myc Pathway in Pancreatic β cells.

Authors:  Lili Gao; Wei Tang; ZhengZheng Ding; DingYu Wang; XiaoQiang Qi; HuiWen Wu; Jun Guo
Journal:  Mol Med       Date:  2015-02-18       Impact factor: 6.354

Review 6.  TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Authors:  Lauren M Workman; Hasem Habelhah
Journal:  Cell Signal       Date:  2013-04-21       Impact factor: 4.315

Review 7.  Caspase control: protagonists of cancer cell apoptosis.

Authors:  M V Fiandalo; N Kyprianou
Journal:  Exp Oncol       Date:  2012-10

8.  High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

Authors:  Claudia Volpi; Francesca Fallarino; Maria T Pallotta; Roberta Bianchi; Carmine Vacca; Maria L Belladonna; Ciriana Orabona; Antonella De Luca; Louis Boon; Luigina Romani; Ursula Grohmann; Paolo Puccetti
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Lysine 63-linked ubiquitination modulates mixed lineage kinase-3 interaction with JIP1 scaffold protein in cytokine-induced pancreatic β cell death.

Authors:  Rohan K Humphrey; Shu Mei A Yu; Aditi Bellary; Sumati Gonuguntla; Myra Yebra; Ulupi S Jhala
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

10.  A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2.

Authors:  M Dafne Cardamone; Anna Krones; Bogdan Tanasa; Havilah Taylor; Laura Ricci; Kenneth A Ohgi; Christopher K Glass; Michael G Rosenfeld; Valentina Perissi
Journal:  Mol Cell       Date:  2012-03-15       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.